Quality & Testing

Lot-specific records

Product inventory is associated with lot records so analytical documentation can be tied to the applicable lot instead of presenting a generic report as if it applied to every unit.

Transparent documentation status

When third-party analytical documentation is available, it can be published with the applicable lot in the COA library. If a final report has not been published, the record is identified as pending rather than presenting an unsupported purity or testing claim.

Research-only positioning

Products are intended for legitimate laboratory and in-vitro research and are not for human or veterinary use. By30Labs does not publish dosing, administration, therapeutic, or clinical-use guidance.

Reading a By30Labs lot record

A lot record connects a specific product and supplied amount to the lot number used for inventory traceability. Where applicable, the same record identifies whether analytical documentation is released or still pending. This keeps a current-lot record distinct from general product reference information and helps prevent an older or unrelated report from being presented as evidence for current inventory.

Published analytical records are intended to be read as lot-specific documents. Researchers should review the lot number, reported test results, and documentation status together rather than treating a single purity value or report as a permanent specification for every future lot of the same product.

Documentation status is part of the record

A pending status means a final third-party report has not yet been published for that lot. A released status means documentation has been associated with the applicable lot record and made available through the storefront. Maintaining that distinction is part of the By30Labs approach to transparent research-supply documentation.